Tag:

Gsk

RAPT stock soars after $2.2B GSK acquisition deal

GSK (GlaxoSmithKline) has agreed to acquire RAPT Therapeutics for $2.2 billion, gaining global rights to the U.S. company's experimental food allergy drug, ozureprubart, which will be integrated into its respiratory and immunology portfolio.

20 Jan 2026-15:46
Japan's Shionogi pays $2.13B to boost stake in ViiV Healthcare

Japan’s Shionogi & Co. announced on Tuesday that it will pay $2.13 billion for new shares in ViiV Healthcare, its joint venture with British drugmaker GSK, raising its stake in the HIV drugmaker to 21.7%.

20 Jan 2026-12:08
Eli Lilly’s Mounjaro becomes India’s top-selling drug by value in October

U.S. pharmaceutical giant Eli Lilly’s weight-loss therapy Mounjaro has become India’s best-selling drug by value in October, surpassing GSK’s antibiotic Augmentin, according to new data from research firm Pharmarack.

07 Nov 2025-17:45
GSK CEO Emma Walmsley to step down

Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down as chief executive of London-based GSK on December 31, concluding more than eight years at the helm of the drugmaker, News.Az reports, citing AP.

29 Sep 2025-13:20
GSK to invest $30 billion in U.S. R&D and factory expansion amid Trump’s UK visit

GlaxoSmithKline (GSK) announced on Wednesday a $30 billion investment in U.S. research, development, and manufacturing over the next five years, coinciding with U.S. President Donald Trump’s second state visit to the UK.

17 Sep 2025-12:37
Italy approves GSK-Vir antibody to treat COVID-19

13 Jul 2021-22:00
Sanofi, GSK announce promising results for COVID vaccine

17 May 2021-22:12

Prev Next